Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant.
Mora
N P
NP
Transplantation Service, Baylor University Medical Center, Dallas, Texas 75246.
Klintmalm
G
G
Solomon
H
H
Goldstein
R M
RM
Gonwa
T A
TA
Husberg
B S
BS
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D016896:Treatment Outcome
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D000666:Amphotericin B; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine